Search





Search





Markets
/
Stocks
/
sxtp
/

60 Degrees Pharmaceuticals Inc

SXTP

Add to Watchlist

1.500USD

-0.070-4.46%

Close 07-27 16:00（ET）Quotes delayed by 15 min

3.96MMarket Cap

LossP/E TTM

60 Degrees Pharmaceuticals Inc

1.500

-0.070-4.46%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

SXTP Cash Flow Statement

You can access the annual and quarterly cash flow statements of 60 Degrees Pharmaceuticals Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-71.63%-2.74M

-3.31%-1.69M

-25.45%-2.11M

-22.04%-1.45M

-40.07%-1.60M

-2473.06%-1.64M

55.20%-1.68M

-279.03%-1.19M

-176.35%-1.14M

3.50%-63.67K

-1122.26%-3.75M

41.34%-313.49K

-302.38%-412.68K

78.82%-65.98K

---307.06K

---534.39K

---102.56K

---311.46K

Net income from continuing operations

-11.34%-2.09M

29.77%-1.44M

-7.25%-2.32M

58.44%-1.73M

-538.64%-1.88M

-0.13%-2.05M

-151.77%-2.16M

-24.84%-4.17M

116.48%427.99K

-6.68%-2.05M

447.17%4.17M

-55.51%-3.34M

-186.25%-2.60M

-40.52%-1.92M

---1.20M

---2.15M

---907.45K

---1.36M

Operating gains losses

53.99%25.86K

-79.16%23.57K

29.86%22.83K

78.76%19.68K

-1.15%16.80K

984.51%113.07K

36.30%17.58K

-14.79%11.01K

20.72%16.99K

12.88%10.43K

67.04%12.90K

64.50%12.92K

76.95%14.08K

16.78%9.24K

--7.72K

--7.85K

--7.96K

--7.91K

Other non-cash items

---251.68K

-84.14%7.00K

-89.32%377.04K

----

-100.00%0.00

-90.42%44.12K

794.24%3.53M

-100.00%0.00

-99.13%13.52K

-34.90%460.32K

133.45%394.95K

30.11%1.01M

822.02%1.55M

143.57%707.12K

--169.18K

--774.54K

--168.39K

--290.32K

Change in working capital

-780.24%-554.26K

-87.84%26.61K

39.52%-159.65K

-79.18%46.06K

392.42%81.48K

-83.27%218.93K

89.57%-263.99K

-75.07%221.24K

-97.76%16.55K

13.88%1.31M

-463.68%-2.53M

6.64%887.52K

17.46%739.48K

52.12%1.15M

--695.71K

--832.24K

--629.54K

--755.31K

-Change in receivables

11725.95%173.81K

200.90%164.39K

-1280.60%-379.00K

873.35%193.21K

98.24%-1.50K

-74.58%-162.93K

-118.93%-27.45K

146.58%19.85K

-130.11%-84.89K

-162.60%-93.32K

91.34%-12.54K

-133.20%-42.62K

-14.16%-36.89K

-37.30%149.08K

---144.71K

--128.34K

---32.31K

--237.76K

-Change in inventory

99.39%-2.00K

-1576.65%-136.91K

206.61%27.73K

-379.82%-26.18K

-1173.25%-330.47K

-93.92%9.27K

-143.77%-26.02K

-91.40%9.36K

128.49%30.79K

1023.32%152.54K

188.97%59.44K

641.08%108.84K

-193.14%-108.08K

-133.96%-16.52K

--20.57K

---20.12K

---36.87K

--48.66K

-Change in prepaid expenses

-663.99%-742.72K

-149.49%-29.86K

0.29%-253.54K

42.68%132.22K

112.95%131.69K

-93.91%60.33K

82.79%-254.27K

273.12%92.67K

243.18%61.84K

3084.26%990.21K

-2445.27%-1.48M

-137.40%-53.53K

166.76%18.02K

-260.12%-33.18K

---58.03K

--143.11K

---26.99K

--20.72K

-Change in payables and accrued expense

-95.52%11.73K

-89.18%35.70K

828.12%445.64K

-351.78%-252.17K

1026.81%261.90K

20.17%330.00K

106.09%48.02K

-55.01%100.15K

-69.83%23.24K

61.54%274.60K

-3153.37%-788.99K

285.86%222.62K

-17.99%77.04K

120.13%169.99K

--25.84K

---119.77K

--93.93K

---844.67K

-Change in other current assets

----

100.00%0.00

--0.00

----

---3.52K

-Change in other current liabilities

----

-100.00%0.00

-254.57%-140.00K

-100.00%0.00

--40.00K

231.16%178.92K

--90.57K

--155.77K

--0.00

--54.03K

Cash from non-recurring investing activities

Cash from operating activities

-71.63%-2.74M

-3.31%-1.69M

-25.45%-2.11M

-22.04%-1.45M

-40.07%-1.60M

-2473.06%-1.64M

55.20%-1.68M

-279.03%-1.19M

-176.35%-1.14M

3.50%-63.67K

-1122.26%-3.75M

41.34%-313.49K

-302.38%-412.68K

78.82%-65.98K

---307.06K

---534.39K

---102.56K

---311.46K

Investing cash flow

Net cash from continuing investing activities

655.93%41.44K

6355.24%135.43K

-34.04%25.49K

-60.41%51.68K

-44.14%5.48K

-96.85%2.10K

38.47%38.64K

620.25%130.56K

198.12%9.81K

13.50%66.56K

2066.67%27.91K

771.07%18.13K

298.55%3.29K

3243.50%58.65K

---1.42K

--2.08K

--826.00

--1.75K

Capital expenditures

655.93%41.44K

6355.24%135.43K

-34.04%25.49K

-60.41%51.68K

-44.14%5.48K

-96.85%2.10K

38.47%38.64K

620.25%130.56K

198.12%9.81K

13.50%66.56K

--27.91K

771.07%18.13K

298.55%3.29K

3243.50%58.65K

----

--2.08K

--826.00

--1.75K

Net cash flow from disposal of fixed assets

1020.24%30.00K

--79.88K

-27.40%10.00K

-47.42%47.32K

--2.68K

-100.00%0.00

655.51%13.77K

--90.00K

----

--55.80K

--1.82K

----

--0.00

----

--0.00

Net cash flow from intangible asset transactions

307.99%11.44K

2547.76%55.55K

-37.72%15.49K

-89.25%4.36K

-71.43%2.80K

-80.51%2.10K

-4.65%24.87K

123.75%40.56K

198.12%9.81K

-81.65%10.76K

1938.20%26.08K

771.07%18.13K

298.55%3.29K

3243.50%58.65K

---1.42K

--2.08K

--826.00

--1.75K

Net cash flow from investment products

-27.69%1.24M

---1.24M

100.00%0.00

--0.00

--1.71M

--0.00

---1.71M

----

Net cash flow from other investing activities

--0.00

----

99.90%-1.78K

----

--0.00

---1.71M

----

Cash from non-current investing activities

Net cash flow from investing activities

-29.89%1.19M

-65220.83%-1.37M

98.54%-25.49K

60.41%-51.68K

17447.85%1.70M

96.85%-2.10K

-6158.80%-1.75M

-620.25%-130.56K

-198.12%-9.81K

-13.50%-66.56K

-2066.67%-27.91K

-771.07%-18.13K

-298.55%-3.29K

-3243.50%-58.65K

--1.42K

---2.08K

---826.00

---1.75K

Financing cash flow

Cash flow from continuous financing activities

98.58%3.37M

47034.02%458.61K

-16.85%4.28M

100.00%0.00

-10.84%1.70M

--973.00

-13.75%5.15M

-100.27%-865.00

943.54%1.90M

100.00%0.00

--5.97M

-75.12%321.07K

--182.39K

-181.85%-68.63K

--0.00

--1.29M

--0.00

--83.84K

Net cash flow from debt Issuance/repayment

----

--0.00

----

--0.00

---1.61M

-41.18%650.00K

----

-100.00%0.00

--0.00

--1.10M

----

--83.84K

Net cash flow from common stock issuance/repurchase

96.72%3.37M

695.01%458.61K

139.09%4.28M

--0.00

-10.53%1.71M

---77.08K

-72.26%1.79M

--0.00

--1.91M

--0.00

--6.45M

----

--0.00

--185.34K

----

Proceeds from issuance of warrants

----

-100.00%0.00

--878.00

-100.00%0.00

-61.44%1.93K

--973.00

-100.00%0.00

--5.00K

--0.00

--1.13M

----

Net cash flow from other financing activities

----

-100.00%0.00

100.00%0.00

-10.99%-18.00K

--77.08K

86774.46%3.36M

98.22%-5.86K

-108.89%-16.22K

100.00%0.00

---3.88K

---328.93K

--182.39K

---68.63K

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

98.58%3.37M

47034.02%458.61K

-16.85%4.28M

100.00%0.00

-10.84%1.70M

--973.00

-13.75%5.15M

-100.27%-865.00

943.54%1.90M

100.00%0.00

--5.97M

-75.12%321.07K

--182.39K

-181.85%-68.63K

--0.00

--1.29M

--0.00

--83.84K

Net cash flow

Beginning cash balance

-9.00%1.51M

24.69%4.12M

24.76%1.97M

19.24%3.45M

-22.55%1.66M

48.78%3.30M

8167.45%1.58M

9551.25%2.89M

708.90%2.14M

404.91%2.22M

-97.46%19.07K

-72.37%29.99K

129.52%264.87K

30.95%439.39K

--751.45K

--108.57K

--115.40K

--335.55K

Current period cash flow changes

1.98%1.83M

-58.76%-2.61M

24.64%2.15M

-12.63%-1.48M

138.25%1.79M

-2058.09%-1.64M

-21.61%1.72M

-11967.18%-1.32M

420.27%752.22K

56.42%-76.06K

804.83%2.20M

-101.70%-10.92K

-3339.84%-234.87K

20.72%-174.53K

---312.06K

--642.88K

---6.83K

---220.15K

Effect of exchange rate changes

160.00%5.94K

27.70%-1.44K

-30.82%1.23K

1021.07%17.24K

-1101.94%-9.90K

-103.68%-1.99K

-80.97%1.78K

511.23%1.54K

36.12%-824.00

189.35%54.17K

245.58%9.34K

99.66%-374.00

-101.34%-1.29K

103.07%18.72K

---6.42K

---110.99K

--96.56K

--9.22K

Ending cash balance

-3.30%3.34M

-9.00%1.51M

24.69%4.12M

24.76%1.97M

19.24%3.45M

-22.55%1.66M

48.78%3.30M

8167.45%1.58M

9551.25%2.89M

708.90%2.14M

404.91%2.22M

-97.46%19.07K

-72.37%29.99K

129.52%264.87K

--439.39K

--751.45K

--108.57K

--115.40K

Free cash flow

-73.63%-2.78M

-11.44%-1.83M

-24.11%-2.13M

-13.88%-1.50M

-39.35%-1.60M

-1159.55%-1.64M

54.51%-1.72M

-297.68%-1.32M

-176.52%-1.15M

-4.50%-130.23K

-1131.35%-3.78M

38.19%-331.62K

-302.35%-415.97K

60.21%-124.62K

---307.06K

---536.47K

---103.38K

---313.22K

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did 60 Degrees Pharmaceuticals Inc Generate?



60 Degrees Pharmaceuticals Inc generated -6.85M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did 60 Degrees Pharmaceuticals Inc's Operating Cash Flow Change Year Over Year?



60 Degrees Pharmaceuticals Inc's operating cash flow increased by -21.26% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does 60 Degrees Pharmaceuticals Inc Spend on Capital Expenditures?



60 Degrees Pharmaceuticals Inc spent 218.08K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has 60 Degrees Pharmaceuticals Inc's Financing Cash Flow Changed?



60 Degrees Pharmaceuticals Inc used 6.44M in financing activities in the latest quarter.

What is free cash flow and why does it matter for SXTP?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was 60 Degrees Pharmaceuticals Inc’s free cash flow in the latest quarter?



Free cash flow was -7.07M reflecting a -21.24% change from the previous year.